Nalagenetics Pte Ltd
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population (NCT05562440) | Nalagenetics Pte Ltd | 2022-11-08 |
| Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study) (NCT05504135) | Nalagenetics Pte Ltd | 2022-10-03 |
| CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population (NCT05501158) | Nalagenetics Pte Ltd | 2021-01-01 |
| Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples (NCT05570266) | Nalagenetics Pte Ltd | 2020-10-13 |
| Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels (NCT04312347) | Nalagenetics Pte Ltd | 2019-09-06 |
Track Nalagenetics Pte Ltd automatically
Every clearance here is in the API, with alerts when new ones post.